ProMIS Neurosciences Inc. (NASDAQ: PMN)
$2.16
-0.0392 ( -1.78% ) 4.5K
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
Market Data
Open
$2.16
Previous close
$2.20
Volume
4.5K
Market cap
$41.52M
Day range
$2.14 - $2.20
52 week range
$0.95 - $8.95
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Jul 05, 2024 |
8-k | 8K-related | 15 | Jun 14, 2024 |
10-q | Quarterly Reports | 68 | May 14, 2024 |
8-k | 8K-related | 17 | May 14, 2024 |
8-k | 8K-related | 17 | Apr 30, 2024 |
def | Proxies and info statements | 4 | Apr 25, 2024 |
ars | Annual reports | 1 | Apr 25, 2024 |
8-k | 8K-related | 17 | Apr 01, 2024 |
10-k | Annual reports | 105 | Apr 01, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |